Mytide Therapeutics has filed a notice of an exempt offering of securities to raise $2,500,000.00 in Equity Investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Mytide Therapeutics is raising $2,500,000.00 in new funding. Sources indicate as part of senior management President, Dale Thomas played a key role…